Discover
KRYS
Krystal Biotech, Inc.
371.58
2 x 364.65
1 x 372.44
bid
ask
-
0.09
0.02%
2 @ 04:01 AM
379.97 +8.39 (2.26%)
| Ytd | 50.72% | |
| 1y | 167.30% |
363.27
day range
377.31
130.50
52 week range
382.54
| Open | 370.57 | Prev Close | 371.67 | Low | 363.27 | High | 377.31 | Mkt Cap | 10.95B |
| Vol | 296.69K | Avg Vol | 312.59K | EPS | 7.47 | P/E | 49.74 | Forward P/E | 36.88 |
| Beta | 0.53 | Short Ratio | 12.47 | Inst. Own | 99.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 308.96 | 200-d Avg | 252.80 | 1yr Est | 349.78 |
KRYS News
zacks.com
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock?
Krystal Biotech (KRYS) witnessed a jump in share price last session on above-average trading volume.
investors.com
Entertainment Stocks Madison Square Garden, Sphere Rally To New Highs
Entertainment leader Sphere stock continues to outperform in the current market environment, setting
benzinga.com
TD Cowen Maintains Buy on Krystal Biotech, Raises Price Target to $403
TD Cowen analyst Ritu Baral maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the pri
benzinga.com
HC Wainwright & Co. Maintains Buy on Krystal Biotech, Raises Price Target to $361
HC Wainwright & Co. analyst Joseph Pantginis maintains Krystal Biotech (NASDAQ:KRYS) with a B
benzinga.com
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $310 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a